Long noncoding RNAs: Important participants and potential therapeutic targets for myocardial ischaemia reperfusion injury

10Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Myocardial ischaemia reperfusion (I/R) injury is one of the leading causes of coronary artery disease-associated morbidity and mortality. While different strategies have been used to limit I/R injuries, cardiac functions often do not recover to the normal level as anticipated. Recent studies have pointed to important roles of long noncoding RNAs (lncRNAs) in the development of myocardial I/R injury. LncRNA is a class of RNA molecules of more than 200 nucleotides in length which are not translated into proteins. I/R causes dysregulation of lncRNA expression in cardiomyocytes, thereby affecting multiple cellular functions including mitochondrial homeostasis, apoptosis, necrosis and autophagy, suggesting that manipulating lncRNAs may be of great potential in counteracting I/R injury-induced myocardial dysfunctions. In this review, we provide an updated summary on our knowledge about contributions of lncRNAs to the development of I/R injury, with an emphasis on the functional links between several well established cardiac lncRNAs and regulation of cellular outcomes post I/R.

Cite

CITATION STYLE

APA

Ding, Y. M., Chan, E. C., Liu, L. C., Liu, Z. W., Wang, Q., Wang, J. L., … Guo, X. S. (2020, November 1). Long noncoding RNAs: Important participants and potential therapeutic targets for myocardial ischaemia reperfusion injury. Clinical and Experimental Pharmacology and Physiology. Blackwell Publishing. https://doi.org/10.1111/1440-1681.13375

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free